Solvent Recovery Whitepaper Online Registration
An Executive Guide to Pharmaceutical Manufacturing Efficiency and the Effect of Environmental Legislation
This paper describes the use and waste of organic solvents in pharmaceutical manufacturing and the possible impact that greenhouse gas legislation, in the form of a carbon tax, may have on solvent usage and pharmaceutical manufacturing costs. It also will review a financial model for solvent recovery in light of the appropriate rate of return on capital and sensitivity to greenhouse gas legislation, as well as the implications on U.S. Food and Drug Administration validation.